The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Feb 2020
Historique:
received: 05 11 2019
revised: 06 12 2019
accepted: 10 12 2019
pubmed: 22 12 2019
medline: 20 3 2021
entrez: 22 12 2019
Statut: ppublish

Résumé

Although intracerebral hemorrhage (ICH) score is used to provide an estimate on the probability of mortality following spontaneous ICH of any cause, its utility has not been exclusively tested in ICH patients with history of treatment with vitamin K antagonists (VKAs) or non-vitamin K oral anticoagulants (NOACs). The aim of the present report is to investigate the utility of ICH score for mortality prognostication of VKA-ICH and NOAC-ICH patients. We used receiver operating characteristic curve analyses to estimate the accuracy parameters for the different values of ICH score in the prognosis of mortality within 30-days after the onset of NOAC-ICH or VKA-ICH. We analyzed data from 108 NOAC-ICH and 241 VKA-ICH patients (median age 76 years, 58% males, median NIHSS score 11 points, median ICH-score 2 points). ICH score of 4 points was uncovered to be the most favorable threshold for the prediction of 30-day mortality both after NOAC-ICH (sensitivity: 57.7%, specificity: 98.8%) or VKA-ICH (sensitivity: 42.1%, specificity: 92.6%). However, comparison of the areas under the curve (AUC) suggested a cumulatively higher (p = .001) predictive value of ICH-score in the prognostication of 30-day mortality after ICH related to the use of NOACs (AUC: 0.92, 95%CI: 0.86-0.98) compared to the ICH related to the use of VKAs (AUC: 0.77, 95%CI: 0.70-0.83). In conclusion, ICH score seems to have an adequate predictive utility in the prognostication of 30-day mortality following an ICH related to the use of oral anticoagulants, with better yield in ICH cases associated with the use of NOACs.

Identifiants

pubmed: 31862517
pii: S0022-510X(19)32393-7
doi: 10.1016/j.jns.2019.116628
pii:
doi:

Substances chimiques

Anticoagulants 0
Vitamin K 12001-79-5

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

116628

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Aristeidis H Katsanos (AH)

Division of Neurology, McMaster University, Population Health Research Institute, Hamilton, ON, Canada. Electronic address: ar.katsanos@gmail.com.

Christos Krogias (C)

Department of Neurology, St. Josef-Hospital, Ruhr University of Bochum, Bochum, Germany.

Vasileios-Arsenios Lioutas (VA)

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Nitin Goyal (N)

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.

Ramin Zand (R)

Department of Neurology, Geisinger Medical Center, Danville, PA, USA.

Vijay K Sharma (VK)

Division of Neurology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Panayiotis Varelas (P)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Konark Malhotra (K)

Allegheny Health Network, Pittsburgh, PA, USA.

Maurizio Paciaroni (M)

Stroke Unit, Division of Cardiovascular Medicine, University of Perugia, Italy.

Aboubakar Sharaf (A)

Department of Neurology, Essentia Health-Duluth Clinic, MN, USA.

Jason Chang (J)

Department of Critical Care Medicine, MedStar Washington Hospital Center, Washington, DC, USA.

Theodore Karapanayiotides (T)

Second Department of Neurology, AHEPA University Hospital, Aristotelian University of Thessaloniki, Thessaloniki, Greece.

Odysseas Kargiotis (O)

Acute Stroke Unit, Metropolitan Hospital, Piraeus, Greece.

Alexandra Pappa (A)

Department of Neurology, University of Thessaly, Larissa, Greece.

Jeffrey Mai (J)

Department of Neurosurgery, Georgetown University, Washington, DC, USA.

Argyrios Tsantes (A)

Laboratory of Haematology and Blood Bank Unit, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.

Efstathios Boviatsis (E)

Department of Neurosurgery, "Attikon" Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Vaia Lambadiari (V)

Second Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Ashkan Shoamanesh (A)

Division of Neurology, McMaster University, Population Health Research Institute, Hamilton, ON, Canada.

Panayiotis D Mitsias (PD)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA; Department of Neurology, School of Medicine, University of Crete, Crete, Greece.

Magdy H Selim (MH)

Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Andrei V Alexandrov (AV)

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.

Georgios Tsivgoulis (G)

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA; Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH